Presentation is loading. Please wait.

Presentation is loading. Please wait.

Treatment of ovarian hyperstimulation syndrome using a dopamine agonist and gonadotropin releasing hormone antagonist: a case series  Nanette L. Rollene,

Similar presentations


Presentation on theme: "Treatment of ovarian hyperstimulation syndrome using a dopamine agonist and gonadotropin releasing hormone antagonist: a case series  Nanette L. Rollene,"— Presentation transcript:

1 Treatment of ovarian hyperstimulation syndrome using a dopamine agonist and gonadotropin releasing hormone antagonist: a case series  Nanette L. Rollene, M.D., Mark H. Amols, M.D., Susan B.A. Hudson, M.D., Charles C. Coddington, M.D.  Fertility and Sterility  Volume 92, Issue 3, Pages 1169.e e17 (September 2009) DOI: /j.fertnstert Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions

2 Figure 1 Weight loss after treatment with cabergoline and ganirelix. Day 0 is the day cabergoline and ganirelix were administered. No weights were recorded for case 2. Fertility and Sterility  , 1169.e e17DOI: ( /j.fertnstert ) Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions


Download ppt "Treatment of ovarian hyperstimulation syndrome using a dopamine agonist and gonadotropin releasing hormone antagonist: a case series  Nanette L. Rollene,"

Similar presentations


Ads by Google